Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
RECOMBINANT EXPRESSION VECTOR FOR PRODUCING NOROVIRUS VACCINE
Document Type and Number:
WIPO Patent Application WO/2017/160124
Kind Code:
A3
Abstract:
The present invention relates to a recombinant expression vector for producing a water-soluble norovirus vaccine, and more particularly, to a recombinant expression vector for producing a water-soluble norovirus vaccine, and a method for using same to produce a water-soluble norovirus vaccine. According to the present invention, a recombinant expression vector and a method for using same to produce a norovirus vaccine can not only efficiently produce a norovirus VLP vaccine from E. coli, but by enabling the production of a VLP that is structurally delicate, allows for the production of an inexpensive and highly efficient norovirus VLP vaccine.

Inventors:
SEONG, Baik Lin (50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, KR)
HWANG, Beom Jeung (50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, KR)
Application Number:
KR2017/002945
Publication Date:
August 02, 2018
Filing Date:
March 17, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
INTHERA INC. (Room No. 612-1, 6th Floor9-22, Pangyo-ro 255beon-gil, Bundang-g, Seongnam-si Gyeonggi-do, 13486, KR)
International Classes:
C07K5/10; C12N9/00; C12N15/70
Foreign References:
KR20130020206A2013-02-27
US20130171185A12013-07-04
KR20080094766A2008-10-24
KR20040016654A2004-02-25
Other References:
CHOI ET AL.: "Protein Solubility and Folding Enhancement by Interaction with RNA", PLOS ONE, vol. 3, no. 7, 16 July 2008 (2008-07-16), XP055106439
Attorney, Agent or Firm:
ERUUM & LEEON INTELLECTUAL PROPERTY LAW FIRM (3rd Floor, 108 Sapyeong-daero,,Seocho-gu, Seoul, 06575, KR)
Download PDF: